Zou, Alicia
Ramanathan, Sudarshini
Dale, Russell C.
Brilot, Fabienne http://orcid.org/0000-0002-7025-2276
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (APP1183968)
University of Sydney (SREI2020, UPA)
Multiple Sclerosis Research Australia
Article History
Received: 10 June 2020
Accepted: 7 July 2020
First Online: 29 July 2020
Competing interests
: A.Z. reports funding from the University of Sydney Postgraduate Award (UPA, Australia) and declares no other competing interests. S.R. is a consultant on an advisory board for UCB on the treatment of MOG antibody-associated demyelination. R.C.D. and F.B. have received honoraria from Biogen Idec and Merck Serono as invited speakers.